Good morning, and thank you for joining Landec’s fourth quarter and fiscal year-end 2013 earnings call. I have with me today, Greg Skinner, our Chief Financial Officer. This call is being webcast by NASDAQ OMX, and can be accessed at Landec’s website at www.landec.com on our Investor Relations page. The webcast will be available for 30 days through August 31, 2013. A replay of the teleconference will be available for one week until midnight Eastern Time, Thursday, August 8, 2013 by calling 888-266-2081 or 703-925-2533. The access code for the replay is 1617672. During today’s call, we may make forward-looking statements that involve certain risks and uncertainties that cause actual results to differ materially. These risks are outlined in our filings with the Securities and Exchange Commission, including the company’s Form 10-K for fiscal year 2012. Fiscal year 2013 was an outstanding year for Landec. Our focus on Landec’s two core businesses is paying off. For the year, we achieved record revenues, which grew 39% to $442 million. And before incurring the earn-out adjustments, net income grew 47% to $18.7 million, and earnings per share grew 43% to $0.70 per share. Both our food and biomedical materials businesses delivered strong revenues and earnings, while continuing to advance market share and leadership in their respective markets, positioning Landec well for future growth, providing products in the growing healthy living space. Apio delivered total revenues for the fiscal year that grew 43% to $399 million along with pre-tax income that increased 34% to $26.6 million, before including the earn-out adjustment. Apio’s value-added food business revenues, including the benefit of acquiring GreenLine in April 2012, increased 54% to $320 million. The contribution to Apio’s net income from the Windset investment increased 33% to $9.2 million. Our Lifecore Biomedical business delivered revenues for the fiscal year that grew 20% to $41 million, and pre-tax income that grew 23% to $9.4 million. Highlights of this important operational year includes: first, generating $1.8 million in operational savings by integrating GreenLine Foods into our Apio food business; second, launching our first product in our vegetable salad product line, and this first product, we call Sweet Kale Salad and this product and other soon will be available nationwide, and in Canada. Third, adding several new food customers as part of our cross-selling effort between GreenLine and Apio customers; and fourth, adding significant sterile filling capacity at Lifecore Biomedical to support existing and new customers which allows us to move up the value-added chain for supplying HA injectable products, as well as non-HA products. And firth, continuing to support new initiatives at Windset farms where we own 20% of the company, which includes the doubling of their California hydroponic greenhouse capacity from three million square-feet to six million square-feet. All in all, a very good year. Let me turn it over to Greg for financial details.